Avinger Inc, a medical device company in commercial stages, has unveiled its suite of image-guided and catheter-based systems used to treat patients with peripheral artery disease (PAD). The US-based firm's innovative lumivascular platform offers a combination of interventional catheters and real-time intravascular imaging, using optical coherence tomography visualization to improve PAD treatment. Avinger's lumivascular products include Lightbox imaging consoles, as well as a family of catheters, such as Ocelot and Tigereye, with Pantheris an image-guided atherectomy device that removes arterial plaque in PAD patients. Additionally, its proprietary design for chronic total occlusion (CTO)-crossing catheters named Wildcat and Kittycat 2 employs a rotational spinning technique for effective navigation. The company has also developed IMAGE-BTK for below-the-knee treatment of PAD lesions. Avinger, Inc. currently supplies these products to interventional cardiologists, vascular surgeons, and interventional radiologists worldwide. Since its incorporation in 2007, the firm is headquartered in Redwood City, California, United States.